Skip to main content
IronOxCLINIC

Iron Infusion Side Effects: Risks and When to Get Help

Clinical director:
Dr Ros
Published
Reading time
7 min read
An earlier clinical review by Dr Rukhsana Jabar is recorded; a dated clinical review of the current text is not recorded.
Updated
Person reclining with a mug.

Quick answer: Side effects vary by IV iron product and by person. For ferric carboxymaltose (Ferinject), the product information lists nausea as the most commonly reported adverse reaction in clinical studies. Other listed effects include headache, dizziness, flushing, infusion-site reactions and low blood phosphate. Serious allergic reactions are classified as rare, and require immediate clinical attention.

If you are considering treatment, ask which product is planned and what monitoring and follow-up apply to you. This page gives general information; it cannot predict an individual reaction or determine whether IV iron is suitable.

Side effects listed for Ferinject

The current UK Summary of Product Characteristics (SmPC) reports adverse reactions from clinical studies and post-marketing experience. It says nausea was the most commonly reported reaction in those data (3.2%). The product-information frequency categories include:

  • Common (at least 1 in 100 and fewer than 1 in 10): nausea, headache, dizziness, flushing, high blood pressure, hypophosphataemia and injection/infusion-site reactions. The SmPC notes that the several reactions grouped under injection/infusion-site reactions are individually uncommon or rare.
  • Uncommon (at least 1 in 1,000 and fewer than 1 in 100): examples include abdominal pain, vomiting, constipation, diarrhoea, indigestion, low blood pressure, fatigue, fever, muscle or joint pain, and changes in taste.

These are the product label's categories, not a prediction for an individual or a result from IronOx patient records. Other IV iron products have their own product information; the Ferinject frequencies should not be applied to every preparation.

Low blood phosphate

Hypophosphataemia is listed as common for Ferinject. The MHRA warns that symptomatic low phosphate has, in some cases after prolonged high-dose exposure and in people with risk factors, led to osteomalacia and fractures. The MHRA advises medical review for new musculoskeletal symptoms or worsening tiredness, and phosphate monitoring for people receiving multiple higher-dose administrations, long-term treatment, or those with relevant risk factors. These symptoms can overlap with iron-deficiency symptoms, so seek medical advice rather than trying to diagnose the cause yourself.

Allergic reactions and infusion monitoring

The Ferinject SmPC classifies anaphylactic reactions as rare (at least 1 in 10,000 and fewer than 1 in 1,000); fatal cases have been reported. The label also lists less severe hypersensitivity reactions separately. A frequency category is not an exact personal-risk estimate.

Tell the infusion staff promptly if you feel unwell during administration. The product information says Ferinject should only be given where staff trained to assess and manage anaphylaxis are immediately available and full resuscitation facilities can be assured. It requires observation for at least 30 minutes after each administration. If you develop severe breathing difficulty, swelling of the face, mouth or throat, collapse, or another severe reaction after leaving, call 999.

Skin discolouration at the infusion site

If Ferinject leaks from the vein into nearby tissue, the product information warns that irritation and potentially long-lasting brown discolouration can occur. Tell staff immediately about pain, burning or swelling around the cannula while the infusion is running. NHS patient guidance notes that staining can take a long time to fade and may be permanent; ask the treating team for advice if you notice discolouration.

How IV iron and tablets differ

Oral ferrous sulfate can cause nausea or vomiting, stomach discomfort, constipation, diarrhoea and darker stools, according to NHS information. Ferinject also lists nausea as common and lists some other digestive effects, including abdominal pain, vomiting, constipation, diarrhoea and indigestion, as uncommon. IV treatment does not mean digestive side effects cannot occur, and the sources do not support a single percentage for how many people taking tablets experience them. The treatments also have different indications and risks.

When to seek help

  • During an infusion: tell the staff immediately about any new or concerning symptoms. The product information requires the infusion to be stopped if hypersensitivity or signs of intolerance occur.
  • After an infusion: seek medical advice for new or worsening tiredness together with muscle or bone pain, particularly after repeated or higher-dose ferric carboxymaltose. Also contact the treating service if symptoms are severe, worsening or persistent.
  • Emergency symptoms: severe difficulty breathing, swelling of the face, lips, tongue or throat, fainting or collapse need emergency help. Call 999.
  • Possible leakage at the cannula: alert staff while treatment is taking place; tell the treating service if skin discolouration appears afterwards.

The Ferinject product information states that iron deficiency must be diagnosed on the basis of laboratory tests; symptoms alone do not establish that diagnosis.

Discussing treatment

To view IronOx Clinic's booking steps, visit its online booking page. For its published service information, see iron infusion risks and side effects.

Sources

Frequently asked questions

What side effects can happen with Ferinject?

The current product information says nausea was the most commonly reported adverse reaction in clinical studies (3.2%). Nausea, headache, dizziness, flushing and high blood pressure are listed as common (at least 1 in 100 and fewer than 1 in 10); frequency depends on the product and the individual.

How long do iron infusion side effects last?

There is no single duration for every person or product. Check the patient information for the preparation used and contact the treating service if symptoms are severe, worsening or not settling.

Can you have an allergic reaction to an iron infusion?

Yes. For Ferinject, the product information classifies anaphylactic reactions as rare (at least 1 in 10,000 and fewer than 1 in 1,000); it also says fatal cases have been reported. Tell the infusion staff immediately about symptoms during treatment.

Is an iron infusion safer than iron tablets?

Neither route can be described as universally safer from these sources. Oral ferrous sulfate can cause digestive side effects; Ferinject can also cause nausea and has distinct risks, including hypersensitivity reactions and low phosphate. The Ferinject product information lists use when oral iron is ineffective, cannot be used, or there is a clinical need to deliver iron rapidly.